Endocrinology & metabolism
Hormones & metabolism clinical trials
Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We’re tracking 7,627 recruiting studies in this area right now.
By phase
- Not applicable5,353
- Phase 2607
- Phase 1557
- Phase 3419
- Phase 4318
- Phase 1/Phase 2288
- Phase 2/Phase 385
Top conditions
- Obesity618
- Ovarian Cancer337
- Pancreatic Cancer287
- Type 2 Diabetes277
- Diabetes192
- Diabetes Mellitus184
- Diabetes Mellitus, Type 2172
- Hypertension138
- Type 1 Diabetes131
- Metabolic Syndrome127
- Obesity & Overweight125
- Breast Cancer111
- Cardiovascular Diseases105
- Overweight105
- Amyotrophic Lateral Sclerosis102
- Pancreas Cancer91
- Colorectal Cancer90
- Endometrial Cancer86
Leading sponsors
- Mayo Clinic87
- Novo Nordisk A/S64
- University of Colorado, Denver53
- Assistance Publique - Hôpitaux de Paris52
- M.D. Anderson Cancer Center42
- Eli Lilly and Company41
- Massachusetts General Hospital41
- IRCCS Azienda Ospedaliero-Universitaria di Bologna40
- National Taiwan University Hospital40
- Cairo University38
Where studies are running
- California521
- Maryland179
- Alabama176
- Arizona170
- Florida166
- Texas158
- Massachusetts151
- New York144
- Colorado115
- Pennsylvania114
Recruiting studies7,627 total
- NCT07055984Recruiting
Predicting diabetes after kidney transplant using microRNA
This study looks at tiny molecules called microRNAs to predict if new diabetes might develop after a kidney transplant. By measuring these molecules in your blood, researchers hope to catch early signs and improve care.
MartinAges 18 years+ - NCT07058753Enrolling by invitation
Prehabilitation before surgery for ovarian cancer patients
This study tests a 'prehabilitation' program — exercises and support — for ovarian cancer patients who are getting chemotherapy before surgery. The goal is to see if getting stronger before the operation helps you recover better.
KatowiceAges 18–80 - NCT07063524Recruiting
Electrical stimulation and heat for people with diabetes
This study tests if a device that uses mild electrical stimulation and controlled heat can help people with diabetes. You will wear a boot for 60 minutes while the device is applied to your leg.
Kalamazoo, MichiganAges 45–75 - NCT01736748Recruiting
Lifestyle coaching for children at high cardiometabolic risk
This study tests a tailored lifestyle program (changes around food and activity) for children who have higher-than-average weight for their age. It may help improve health habits and reduce future risk related to heart and metabolic health.
Montreal, QuebecAges 6–18 - NCT06987279Recruiting
Probiotics for hormone balance in overweight women
This trial tests whether a specific probiotic, Lactobacillus plantarum, can help regulate hormones in overweight women. It involves taking daily probiotic capsules and providing samples over a period of time.
Zhengzhou, HenanAges 18–40 - NCT04520932Recruiting
Radiofrequency treatment for small nonfunctioning pancreatic tumors
This trial tests whether heating (radiofrequency) treatment guided by a special ultrasound scope can control small pancreatic neuroendocrine tumors. It may help patients whose tumors are very small and do not release hormones.
MarseilleAges 18–80 - NCT06989008Recruiting
Improving diabetes care with wearable sensors
This study tests if wearing two devices (a continuous glucose monitor and a sports wristband) can help improve diabetes care. It focuses on people with type 2 diabetes who live in certain Chicago neighborhoods and are willing to use the devices.
Chicago, IllinoisAges 18–65 - NCT06906081RecruitingPhase 2
Finerenone for diabetic nerve damage (FibroCAN study)
This trial tests if finerenone can help people with type 2 diabetes who have early signs of nerve damage affecting their heart and blood vessels (cardiovascular autonomic neuropathy). It aims to see if the drug can improve heart rate control and reduce symptoms.
GistrupAges 40 years+ - NCT06935162RecruitingPhase 2
Teclistamab for previously treated AL amyloidosis
This trial tests a new drug called teclistamab for people with AL amyloidosis whose disease has not responded well to previous treatments. It aims to see if the drug can help control the disease.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06852755Recruiting
Finding markers to track menopause in women
This study looks for biological signs that can help monitor menopause. It may help women understand their menopause transition better.
New Taipei CityAges 20 years+ - NCT06989723RecruitingPhase 4
Pioglitazone and empagliflozin for fatty liver in type 2 diabetes
This trial tests two diabetes pills (pioglitazone and empagliflozin) to see if they can reduce liver fat in people with type 2 diabetes and fatty liver disease. It may help if your diabetes is not well controlled and you have a fatty liver confirmed by a special ultrasound scan.
Seongnam-siAges 20 years+ - NCT04375280Recruiting
Study of mobility problems in people with long-term illnesses
This study observes how people with chronic health conditions affect their ability to move and do everyday activities. It may help researchers better understand mobility limits and what factors influence them.
Clermont-FerrandAges 18–90 - NCT06989697RecruitingPhase 3
Cilostazol and ginkgo for memory in older adults with diabetes
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
Seongnam-siAges 60 years+ - NCT06988670RecruitingPhase 2
Testing EXT608 for adults with hypoparathyroidism
This trial tests a new medicine called EXT608 for adults with hypoparathyroidism. It aims to see if this medicine can help manage calcium levels better than current treatments.
Buenos Aires, Buenos Aires F.D.Ages 18–65 - NCT06989190Recruiting
Study of blood vessel damage in type 1 diabetes
This study looks at how type 1 diabetes affects small blood vessels, especially in the eyes, kidneys, and feet. It tests a special camera and other devices to see how severe the damage is, which may help doctors find better ways to treat complications early.
StockholmAges 18–60 - NCT07046767Recruiting
Amnion grafts for slow-healing leg or foot ulcers
This trial tests if a special graft made from amniotic tissue can help heal chronic leg or foot ulcers that haven't improved much in the last month. It may be an option if you have a non-healing venous leg ulcer or diabetic foot ulcer that still shows some signs of healing.
Oxnard, CaliforniaAges 18 years+ - NCT07051564Recruiting
Cell injection study for type 1 diabetes
This trial tests a new cell injection (CNK-UT009) for adults with type 1 diabetes. The goal is to see if it can help manage blood sugar and reduce insulin needs.
Zibo, ShandongAges 18–65 - NCT07046546Recruiting
Thyroid nodule embolization pilot trial
This trial tests a minimally invasive procedure that blocks blood flow to large thyroid nodules, which can shrink them and relieve symptoms like trouble swallowing or cosmetic concerns. It's an option for people with benign nodules or Graves disease who want to avoid surgery or other treatments.
ReadingAges 18 years+ - NCT06989216Recruiting
Skin imaging study for adults
This trial uses advanced imaging to take detailed pictures of your skin. It may help doctors better understand and diagnose skin conditions.
StockholmAges 18 years+ - NCT07054125Recruiting
CGM, education, and peer support for type 2 diabetes
This trial tests if using a continuous glucose monitor (a small sensor that tracks your blood sugar), combined with diabetes education and support from others with diabetes, can help people with type 2 diabetes better control their blood sugar. You may qualify if your blood sugar is not well controlled (A1c above 8%).
Asheville, North CarolinaAges 18 years+ - NCT07049055RecruitingPhase 1/Phase 2
EDV nanocell therapy with chemo for advanced pancreatic cancer
This trial tests a new targeted therapy (EDV nanocells) combined with two standard chemotherapy drugs for people with metastatic pancreatic cancer. It is for patients whose cancer has progressed after first-line FOLFIRINOX or NALIRIFOX treatment.
El Segundo, CaliforniaAges 18 years+ - NCT07048795Recruiting
Testing mylife CamAPS FX system in type 1 diabetes patients in France
This study tests a new automated insulin delivery system (mylife CamAPS FX) for people with type 1 diabetes. It aims to see how well the system works when paired with a Dexcom G6 continuous glucose monitor.
AmiensAges Any age - NCT07048158Recruiting
A drink for heart health
This study tests a drink called 'Perfect Heartio' to see if it supports cardiovascular health in healthy adults. It may help improve heart function or reduce risk factors.
Cheras, Kuala LumpurAges 18 years+ - NCT07054515RecruitingPhase 3
Study of oral nizubaglustat for rare genetic disorders
This trial tests a new oral medicine, nizubaglustat (AZ-3102), for children and adults (4+) with late-infantile or juvenile Niemann-Pick type C, GM1, or GM2 gangliosidosis. It aims to see if the drug is safe and helps slow disease progression.
Oakland, CaliforniaAges 4 years+
Common questions
- How many hormones & metabolism clinical trials are recruiting?
- Clin2 is tracking 7,627 recruiting endocrinology & metabolism studies from the U.S. registry right now, out of 11,981 we cover in this area in total.
- What does “Hormones & metabolism” cover here?
- Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We group each study into hormones & metabolism based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a hormones & metabolism trial near me?
- Use the search to filter hormones & metabolism studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.